28Dec/22

Science: Major Progress in Universal Influenza Vaccine

December 28, 2022Popular Vaccine, Vaccine NewsInfluenza Vaccine, mRNA Vaccinebiovaccine

In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania found that an experimental mRNA vaccine against all 20 known influenza virus subtypes provides extensive protectionRead More…

27Jun/22

News and Facts About Monkeypox Virus

June 27, 2022Popular Vaccine, Vaccine NewsMonkeypox Vaccine, Smallpox Vaccinebiovaccine

Monkeypox is a rare viral infectious disease similar to human smallpox caused by monkeypox virus. It is also a zoonosis. Mainly found in the rainforest regions of central and western Africa. ItRead More…

28Feb/22

Nat Commun: Natural env Trimer Produces Tier-2 Neutralizing Antibodies Against HIV In Vivo

February 28, 2022Popular Vaccine, Vaccine News, Vaccine ResearchHIV vaccine, Neutralizing Antibodies, Tier-2biovaccine

Nearly 40 years after the discovery of HIV, it has killed 36.3 million people, but so far there is still no effective vaccine available. In a new study, however, researchers from theRead More…

14Sep/21

Nature Communication: Cancer vaccine may effectively overcome the drug tolerance of cancer cells

September 14, 2021Popular Vaccine, Vaccine News, Vaccine Researchcancer vaccine, tumor vaccinebiovaccine

In the clinical trial of oncolytic vesicular stomatitis virus expressing interferon-β (VSV-IFN-β), a large group of patients initially achieved a preliminary response, but then the disease relapsed. A few days ago, inRead More…

27Jul/21

What is mRNA vaccine?

July 27, 2021Popular VaccinemRNA Vaccine, non-replicating mRNA, self-amplifying mRNAbiovaccine

mRNA vaccine is to transfer RNA to the cells of the body to express and produce protein antigens, so as to induce the body to produce an immune response against the antigen,Read More…

10Dec/20

RSV Vaccine R&D: Advancing in a Rocky Path with Hope

December 10, 2020Popular Vaccine, Vaccine NewsRespiratory Syncytial Virus, ResVax, RSV vaccinebiovaccine

Respiratory syncytial virus (RSV) is the most common pathogen of viral pneumonia in children, which occurs mostly in newborns and infants less than 6 months old, as well as in immunodeficiency patientsRead More…

12Jul/20

New Research: novel coronavirus’s evolution clues

July 12, 2020Popular Vaccine, Vaccine Newscoronavirus, RaTG13, SARS-CoV-2, spike glycoproteins, vaccine designbiovaccine

According to a new virological research paper published in Nature-structure and Molecular Biology, a professional academic journal of Springer Nature, through a comparative study on the structure of the novel coronavirus (SARS-CoV-2)Read More…

04Jun/20

Russia has developed intranasal novel coronavirus vaccine

June 4, 2020Popular Vaccine, Vaccine NewsCOVID-19, novel coronavirus vaccine, SARS-CoV-2biovaccine

Mark Shotov, director of the “Vector” National Virology and Biotechnology Research Center of the Russian Federation’s Consumer Rights Protection and Public Welfare Supervision Agency, said the center had developed an intranasal novelRead More…

08May/20

Lancet Infect Dis: MERS coronavirus vaccine is expected to treat MERS

May 8, 2020Popular Vaccine, Vaccine ResearchMERS, MVA, MVA-MERS-S, SARS-CoV-2, the Middle East Respiratory Syndrome coronavirusbiovaccine

Recently, researchers have found that a Middle East respiratory syndrome coronavirus vaccine has shown efficacy in human trials, which may help to develop a vaccine against the new virus. Professor Marylyn Addo,Read More…

07Apr/20

mRNA vaccine of SARS-CoV-2 is under development

April 7, 2020Popular Vaccine, Vaccine NewsCOVID-19, mRNA Vaccine, vaccine developmentbiovaccine

Sanofi Pasteur recently announced the development of a new mRNA vaccine for COVID-19. In February, Sanofi Pasteur announced that it would begin to develop a recombinant protein candidate vaccine for COVID-19. DavidRead More…